Your browser doesn't support javascript.
loading
COVID-19 Vaccine Allergy Safety Track (VAS-Track) pathway: real-world outcomes on vaccination rates and antibody protection.
Chiang, Valerie; To, Kelvin Kai Wang; Hung, Ivan Fan Ngai; Saha, Chinmoy; Yim, Jackie Sh; Wong, Jane Chi Yan; Au, Elaine Yl; Chan, Tik Suet; Kan, Andy Ka Chun; Hong, Yuh Dong; Ye, Jiaxi; Ng, Carmen S; Ho, Carmen Tk; Lau, Chak Sing; Lam, Tommy Ty; Chan, Esther Wy; Quan, Jianchao; Li, Philip Hei.
Afiliação
  • Chiang V; Division of Clinical Immunology, Department of Pathology, Queen Mary Hospital, Hong Kong.
  • To KKW; Department of Microbiology, Queen Mary Hospital, The University of Hong Kong, Hong Kong.
  • Hung IFN; Division of Infectious Diseases, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong.
  • Saha C; Division of Rheumatology and Clinical Immunology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong.
  • Yim JS; Division of Rheumatology and Clinical Immunology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong.
  • Wong JCY; Division of Rheumatology and Clinical Immunology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong.
  • Au EY; Division of Clinical Immunology, Department of Pathology, Queen Mary Hospital, Hong Kong.
  • Chan TS; Division of Rheumatology and Clinical Immunology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong.
  • Kan AKC; Division of Rheumatology and Clinical Immunology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong.
  • Hong YD; School of Public Health, The University of Hong Kong, Hong Kong.
  • Ye J; School of Public Health, The University of Hong Kong, Hong Kong.
  • Ng CS; School of Public Health, The University of Hong Kong, Hong Kong.
  • Ho CT; Division of Rheumatology and Clinical Immunology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong.
  • Lau CS; Division of Rheumatology and Clinical Immunology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong.
  • Lam TT; School of Public Health, The University of Hong Kong, Hong Kong.
  • Chan EW; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong.
  • Quan J; School of Public Health, The University of Hong Kong, Hong Kong.
  • Li PH; Division of Rheumatology and Clinical Immunology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong.
Article em En | MEDLINE | ID: mdl-36592163

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article